Difference 215498000 exceeds tolerance 4036704.000. Presentation or filing-vintage differences need review.
FULLER H B CO (FUL) reported revenue of $3.47B and net income of $151.97M for the fiscal year ended 2025-11-29. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from FULLER H B CO’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2025-11-29 | 2024-11-30 | 2023-12-02 | 2022-12-03 | 2021-11-27 | 2020-11-28 | 2019-11-30 | 2018-12-01 | 2017-12-02 | 2016-12-03 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.47B | $3.57B | $3.51B | $3.75B | $3.28B | $2.79B | $2.90B | $3.04B | $2.31B | $2.09B |
| Cost of revenue | $2.39B | $2.51B | $2.50B | $2.79B | $2.43B | $2.03B | $2.09B | $2.21B | $1.71B | $1.49B |
| Gross profit | $1.08B | $1.06B | $1.01B | $963.70M | $845.32M | $756.65M | $806.92M | $828.16M | $598.99M | $605.82M |
| Operating income | Unavailable | $348.22M | $355.14M | $322.72M | $252.61M | $218.32M | $225.99M | $237.89M | $119.53M | $198.18M |
| Net income | $151.97M | $130.26M | $144.91M | $180.31M | $161.39M | $123.72M | $130.82M | $171.21M | $59.42M | $121.66M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 55.36M | shares 56.63M | shares 55.96M | shares 55.27M | shares 54.32M | shares 52.52M | shares 51.98M | shares 51.98M | shares 51.62M | shares 51.27M |
| Pretax income | $215.42M | $182.66M | $234.16M | $251.93M | $216.85M | $158.36M | $172.83M | $156.73M | $60.60M | $163.44M |
| Income tax expense | $67.13M | $56.38M | $93.53M | $77.19M | $63.03M | $41.92M | $49.41M | -$6.36M | $9.81M | $48.92M |
| Diluted EPS | $2.75 | $2.30 | $2.59 | $3.26 | $2.97 | $2.36 | $2.52 | $3.29 | $1.15 | $2.37 |
| Selling, general & administrative | $725.58M | $713.66M | $653.76M | $640.98M | $592.71M | $538.33M | $580.93M | $590.27M | $479.46M | $407.64M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-11-29 | 2024-11-30 | 2023-12-02 | 2022-12-03 | 2021-11-27 | 2020-11-28 | 2019-11-30 | 2018-12-01 | 2017-12-02 | 2016-12-03 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $107.21M | $169.35M | $179.45M | $79.91M | $61.79M | $100.53M | $112.19M | $150.79M | $194.40M | $142.24M |
| Total assets | $5.18B | $4.93B | $4.72B | $4.46B | $4.27B | $4.04B | $3.99B | $4.18B | $4.37B | $2.06B |
| Current assets | $1.26B | $1.30B | $1.31B | $1.30B | $1.22B | $1.02B | $1.03B | $1.09B | $1.16B | $811.25M |
| Total liabilities | $3.18B | $3.10B | $2.97B | $2.85B | $2.68B | $2.65B | $2.76B | $3.02B | $3.32B | $1.11B |
| Current liabilities | $743.36M | $719.29M | $692.81M | $705.73M | $736.85M | $530.13M | $542.16M | $546.12M | $504.91M | $391.84M |
| Total equity incl. NCI | $2.00B | $1.83B | $1.76B | $1.61B | $1.60B | $1.60B | $1.22B | $1.15B | $1.05B | $944.89M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $4.28M |
| Inventory | $471.96M | $467.50M | $442.04M | $491.78M | $448.40M | $323.21M | $337.27M | $348.46M | $372.10M | $247.40M |
| Accounts receivable | $564.34M | $558.34M | $577.93M | $607.36M | $614.64M | $514.92M | $493.18M | $495.01M | $473.70M | $351.13M |
| Goodwill | $1.68B | $1.53B | $1.49B | $1.39B | $1.30B | $1.31B | $1.28B | $1.31B | $1.34B | $366.25M |
| Long-term debt | $2.02B | $2.01B | $1.84B | $1.74B | $1.59B | $1.76B | $1.90B | $2.14B | $2.40B | $585.76M |
| Accounts payable | $470.13M | $491.44M | $439.70M | $460.67M | $500.32M | $316.46M | $298.87M | $273.38M | $268.47M | $162.96M |
Cash flow
| Metric | 2025-11-29 | 2024-11-30 | 2023-12-02 | 2022-12-03 | 2021-11-27 | 2020-11-28 | 2019-11-30 | 2018-12-01 | 2017-12-02 | 2016-12-03 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $263.49M | $302.44M | $378.40M | $256.51M | $213.32M | $331.56M | $269.18M | $253.31M | $166.32M | $195.69M |
| Capital expenditures | $142.28M | $139.24M | $119.14M | $129.96M | $96.09M | $87.29M | $61.98M | $68.26M | $54.93M | $63.31M |
| Investing cash flow | -$232.25M | -$407.08M | -$319.20M | -$375.29M | -$94.66M | -$109.46M | $7.40M | -$61.84M | -$1.80B | -$111.52M |
| Financing cash flow | -$107.90M | $112.09M | $35.14M | $160.32M | -$154.07M | -$239.21M | -$315.05M | -$228.60M | $1.68B | -$52.59M |
| Net change in cash | -$62.14M | -$10.10M | $99.54M | $18.12M | -$38.75M | -$11.66M | -$38.60M | -$43.60M | $52.15M | $23.08M |
| Stock-based compensation | $22.06M | $21.91M | $19.91M | $24.37M | $22.37M | $16.91M | $24.00M | $17.11M | $17.50M | $13.34M |
| Common dividends paid | $50.27M | $47.60M | $43.40M | $39.21M | $34.86M | $33.46M | $32.36M | $31.12M | $29.61M | $27.52M |
| Common share repurchases | $60.71M | $39.56M | $2.57M | $3.95M | $2.68M | $3.43M | $3.03M | $4.69M | $21.83M | $23.23M |
| Depreciation & amortization | $178.32M | $174.71M | $159.84M | $146.98M | $143.17M | $138.82M | $141.21M | $145.13M | $87.32M | $77.68M |
Derived
| Metric | 2025-11-29 | 2024-11-30 | 2023-12-02 | 2022-12-03 | 2021-11-27 | 2020-11-28 | 2019-11-30 | 2018-12-01 | 2017-12-02 | 2016-12-03 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $121.22M | $163.20M | $259.26M | $126.55M | $117.23M | $244.27M | $207.20M | $185.05M | $111.39M | $132.38M |
| Gross margin | 31.1% | 29.8% | 28.7% | 25.7% | 25.8% | 27.1% | 27.9% | 27.2% | 26.0% | 28.9% |
| Operating margin | Unavailable | Unavailable | Unavailable | 8.6% | 7.7% | 7.8% | 7.8% | 7.8% | 5.2% | 9.5% |
| FCF margin | 3.5% | 4.6% | 7.4% | 3.4% | 3.6% | 8.8% | 7.2% | 6.1% | 4.8% | 6.3% |
| SBC / revenue | 0.6% | 0.6% | 0.6% | 0.6% | 0.7% | 0.6% | 0.8% | 0.6% | 0.8% | 0.6% |
| Current ratio | 1.70x | 1.81x | 1.89x | 1.84x | 1.66x | 1.92x | 1.91x | 2.00x | 2.29x | 2.07x |
| Revenue YoY growth | -2.7% | 1.6% | -6.4% | 14.4% | 17.5% | -3.7% | -4.7% | 31.9% | 10.1% | Unavailable |
| Net margin | 4.4% | 3.6% | 4.1% | 4.8% | 4.9% | 4.4% | 4.5% | 5.6% | 2.6% | 5.8% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 4.1% | 3.9% | 3.4% | 3.5% | 2.9% | 3.1% | 2.1% | 2.2% | 2.4% | 3.0% |
| Long-term debt / equity | 1.01x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 31.2% | 30.9% | 39.9% | 30.6% | 29.1% | 26.5% | 28.6% | -4.1% | 16.2% | 29.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open FUL in the interactive workspace to inspect any figure back to its filing.
Source filings
Companies in the same industry
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
Difference 6621000 exceeds tolerance 2055868.000. Presentation or filing-vintage differences need review.